Dear Colleagues,

It is with great anticipation and excitement that I extend on behalf of the organizing committee a cordial invitation to all of you to join the 9th International Congress of Internal Medicine which will be held this year on March 9-11, 2017 in Athens, Greece.

In this website you will find all the information needed concerning the implementation of the congress. The material will soon be enriched with further details for your convenience.

This is a major annual event in Greece attended nationally and internationally by upwards of 600-700 attendees from all over the country and European countries and with the active participation of established international scientists and experts.

The last years the organizing and scientific committee has been focusing on a single goal: hopefully to make this congress an important scientific event beyond the Greek borders, open to friendships and collaborations, that will gain worldwide warm acceptance and recognition for its scientific merit. The success of the past congresses shows us that we walk on the right path towards this goal, enhances our passion and willingness for continuing this educational undertaking.

At this point more than 70 established international scientists and experts of great impact have already confirmed their participation as faculty members. More information along with the preliminary program will be announced on the early of August 2016.

The scientific program will also include the traditional form of the abstract based sessions and will provide young-and not only-colleagues with a great opportunity to present their work, research and clinical experience through oral presentations and e-posters covering various section fields of Internal Medicine. Therefore we encourage interested colleagues to actively participate in the programme and submit abstracts of their work through the website of the Congress.

We are confident that the Congress will represent for all participants an unforgettable personal and professional experience, and we look forward to welcoming you in Athens.

 

Best regards,

The President of the Organizing Committee
George N. Dalekos

Professor of Medicine,
President, Institute of Internal Medicine and Hepatology,
President, Hellenic Association for the Study of the Liver,
Vice President, Internal Medicine Society of Northern Greece,
Head, Department of Medicine and Research Laboratory of Internal Medicine,
Medical School, University of Thessaly, Larissa, Greece

Abstract submission on line available via website:
July 2016
…………………………………………..
Preliminary Programme available via website:
July 2016
…………………………………………..
Abstract Submission Deadline:
November 30, 2016 (deadline will not be extended)
…………………………………………..
Notification of Acceptance/Rejection of Abstracts:
December 20, 2016
…………………………………………..
Availability for Accommodation Booking
December 30, 2016
…………………………………………..
Final Programme available via website:
January 2017

calendar_new
afises
Venue
Hilton Athens Hotel, Greece
46 Vasilissis Sofias Avenue,11528
Tel:(+30)210-7281000
Fax:(+30)210-7281111
Dates
Thursday, March 9th, 2017
Friday, March 10th, 2017
Saturday, March 11th, 2017
Official Language
The official language of the Congress is English.
Contact
Organizing-Administrative Bureau

CONFERRE LTD
Address: Stavrou Niarchou Avenue,
Mares Position 455 00 Ioannina,Greece
Tel.: (+30) 26510 68610,
Fax: (+30) 26510 68611
E-mail: info@conferre.gr
Website: www.conferre.gr

Organizers

INSTITUTE OF INTERNAL MEDICINE & HEPATOLOGY, LARISSA, GREECE

DEPARTMENT OF MEDICINE & RESEARCH LABORATORY OF INTERNAL MEDICINE,
       UNIVERSITY OF THESSALY MEDICAL SCHOOL, LARISSA, GREECE
       Director: Professor G.N. Dalekos

Under the auspices of the

UNIVERSITY OF THESSALY MEDICAL SCHOOL, LARISSA, GREECE

ORGANIZING COMMITTEE (BOARD MEMBERS OF THE INSTITUTE OF INTERNAL MEDICINE & HEPATOLOGY)
President: G.N. Dalekos
Members: K. Krapis K.P. Makaritsis C. Mandros G. Ntaios
SCIENTIFIC COMMITTEE
M. Akova A. Alexopoulou P. Amarenco Q. Anstee M. Blank
S. Blot Y. de Boer H.R. van Buuren M. Burnier L. Christou
G.L. Daikos G.N. Dalekos G.D. Dimitriadis G. Dimopoulos Μ.-Α. Dimopoulos
S. Dourakis M. Ekstedt Μ. Elisaf J. Ferro A. Floreani
Ν.K. Gatselis S. Georgiadou L. Guillevin C. Hadjichristodoulou S.J. Hadziyannis
Α. Hatzitolios G. Hirschfield T. Hoffman G.K. Hovingh C. Jamin
J. Jens Ν.L. Katsilambros M. Kohrmann J. Koskinas V. Kotsis
C. Labropoulou-Karatza R. Liberal G. Lip Κ.P. Makaritsis Ε. Maltezos
P.M. Mannucci M.N. Manoussakis C. Marañón H. Mattle F. Menichetti
D.L. Menucci N. Montano P. Montravers V. Mouchtouri H.Μ. Moutsopoulos
P. Nilsson G. Ntaios C.J. Packard R. Pálsson N. Papanas
G. Papatheodoridis D. Papazoglou A. Pares T.R. Pedersen G. Petrikkos
J. Putaala V. Ratziu Y. Renaudineau Ε.I. Rigopoulou Κ. Ritis
M. Rizzo D. Samonakis M. Samson D. Sereni P.P. Sfikakis
K. Spengos A. Stefos D. Strbian H. Toplaks Ε.V. Tsiano
E.A. Tsochatzis S. Unal P. Valensi Κ. Vemmos D. Vergani
P.G. Vlachoyiannopoulos H. Wedemeyer C. Weimar C. Yurdaydin Κ. Zachou
A. Zanchetti D. Ziegler

SPEAKERS (confirmed up to July 2016)

COUNTRIES

DAYS

Preliminary Scientific Program

Importance of European registries on rare liver diseases: The paradigm of autoimmune hepatitis
Rodrigo Liberal (London, UK)

Chairperson: Dimitrios Samonakis (Heraklion, Greece)

Should we treat everyone above 60 years with a statin?
Chris J Packard (Glasgow, UK)
Familial hypercholesterolemia diagnosis and treatment: Can we perform better?
G. Kees Hovingh (Amsterdam, The Netherlands)
PCSK9 inhibition: What is hot in 2017?
Terje Rolf Pedersen (Oslo, Norway)

Chairperson: Moses Elisaf (Ioannina, Greece)

Pros
Michel Burnier (Lausanne, Switzerland)
Cons
Alberto Zanchetti (Milan, Italy)

Chairperson: Alberto Zanchetti (Milan, Italy)

Hellenic Stroke Organization

Stroke in the young
Jukka Putaala (Helsinki, Finland)
Drug-induced stroke
Jose Ferro (Lisbon, Portugal)
Can we predict thrombolysis-associated symptomatic intracranial hemorrhage?
Daniel Strbian (Helsinki, Finland)
Management of intracranial artery stenosis
Christian Weimar (Essen, Germany)

Chairpersons: Jose Ferro (Lisbon, Portugal), George Ntaios (Larissa, Greece)

Hellenic Stroke Organization

Patent foramen ovale in cryptogenic stroke: Closure, antiplatelets or anticoagulants?
Heinrich Mattle (Bern, Switzerland)
Optimal strategy for detection of atrial fibrillation in patients with cryptogenic stroke
Martin Kohrmann (Erlangen, Germany)
Acute treatment in patients with acute ischemic stroke treated with oral anticoagulants
George Ntaios (Larissa, Greece)

Chairpersons: Heinrich Mattle (Bern, Switzerland), Konstantinos Spengos (Athens, Greece)

Welcome

Inaugural Lecture
Improving health care by innovations and clinical research
Daniel Sereni (Paris, France)
President of the Federation for the Development of Internal Medicine in Europe (FDIME)

Epidemiology, definition and diagnosis of obesities
Hermann Toplak (Graz, Austria)
Obesity, impaired glucose metabolism and vascular changes
Peter Nilsson (Malmo, Sweden)
Mechanisms of obesity induced hypertension
Vasilios Kotsis (Thessaloniki, Greece)
Novel drugs in the treatment of obesity
Jordan Jens (Hannover, Germany)

Chairpersons: Hermann Toplak (Graz, Austria), Peter Nilsson (Malmo, Sweden)

Hellenic Association for the Study of the Liver

Chronic hepatitis B: Discontinuation of oral antivirals
Stephanos J. Hadziyannis (Athens, Greece)
Chronic hepatitis C: Challenges in special populations
Heiner Wedemeyer (Hannover, Germany)
Chronic hepatitis delta: An update
Cihan Yurdaydin (Ankara, Turkey)

Chairpersons: Stephanos J. Hadziyannis (Athens, Greece), John Koskinas (Athens, Greece)

Hellenic Diabetes Association

Novel approaches to manage dyslipidaemia, NAFLD and CV risk in type 2 diabetes
Manfredi Rizzo (Palermo, Italy)
Silent myocardial ischaemia in diabetes: new developments
Paul Valensi (Paris, France)
Diabetic neuropathy: new developments in early diagnosis and treatment
Dan Ziegler (Düsseldorf, Germany)

Chairpersons: Nikolaos Papanas (Alexandroupolis, Greece), George Dimitriadis (Athens, Greece)


Treatment of ANCA-associated vasculitis: Questions and concerns
Loic Guillevin (Paris, France)
Biological-targeted treatments in giant cell arteritis and eosinophilic granulomatosis with polyangitis (Churg-Strauss)
Maxime Samson (Dijon, France)
Primary Sjögren’s syndrome: How to improve specific treatment?
Yves Renaudineau (Brest, France)
Axial spondyloarthritis and psoriatic arthritis: Emerging treatment strategies
Menelaos N. Manoussakis (Athens, Greece)

Chairpersons: Loic Guillevin (Paris, France), Yves Renaudineau (Brest, France)

Choosing antibiotics in difficult to treat staphylococcal infections
Francesco Menichetti (Pisa, Italy)
Optimizing treatment strategies in S. aureus bacteremia
Serhat Unal (Ankara, Turkey)

Chairperson: Serhat Unal (Ankara, Turkey)

Hellenic Stroke Organization

Transient ischemic attack and minor strokes: definition, diagnosis, imaging and natural history
Pierre Amarenco (Paris,France)

Chairperson: Konstantinos Vemmos (Athens, Greece)

European Federation of Internal Medicine (EFIM)

European Curriculum of Internal Medicine
Runólfur Pálsson (Reykjavik, Iceland)
Choosing wisely: To be or not to be – that’s the question
Nicola Montano (Milan,Italy)
The role of EFIM publications for trainees and specialists
Pier Mannucio Mannucci (Milan,Italy)

Chairpersons: Pier Mannucio Mannucci (Milan, Italy), George N. Dalekos (Larissa, Greece)

Selecting the appropriate antithrombotic strategy in atrial fibrillation
Gregory Lip (Birmingham, UK)

Chairperson: George Ntaios (Larissa, Greece)

Global health and population movements
Varvara Mouchtouri (Larissa, Greece)
The role of points of entry (ports, airports, ground, crossings) in global health security
Daniel Lins Menucci (Lyon, France)
The impact of the International Health Regulations 2005 in global health security
Thomas Hoffman
The role of European Union in the global health security
TBA

Chairperson: Christos Hadjichristodoulou (Larissa, Greece)

TBA
TBA
TBA
TBA

Chairperson: Runólfur Pálsson (Reykjavik, Iceland)

Autoimmune serology: The strategy, methodology and clinical governance
Diego Vergani (London, UK)

Chairperson: Panayiotis G. Vlachoyiannopoulos (Athens, Greece)

Scientific and practical aspects of registries in primary biliary cholangitis (PBC)
Henk R. van Buuren (Rotterdam, The Netherlands)
PBC: Old and novel therapies
Annarosa Floreani (Padova, Italy)
Variant syndromes: Classification and management
Albert Pares (Barcelona, Spain)
Deranged cholestatic enzymes in a patient with inflammatory bowel disease: What to do?
Gideon Hirschfield (Birmingham, UK)

Chairpersons: Gideon Hirschfield (Birmingham, UK), Henk R. van Buuren (Rotterdam, The Netherlands)

Disease specific IVIG to treat diverse autoimmune diseases
Miri Blank (Tel Aviv, Israel)

Chairperson: Nikolaos K. Gatselis (Larissa, Greece)

Prevention of ventilator-associated pneumonia (VAP): could be realistic?
Stijn Blot (Ghent, Belgium)
Reducing the antifungal drugs consumption in the ICU
Philippe Montravers (Paris, France)
Fighting multi-drug resistant (MDR) pathogens in the ICU
Murat Akova (Ankara, Turkey)

Chairperson: George Dimopoulos (Athens, Greece)

Steatosis and metabolic risk factors: Who is at risk of liver disease progression
Mattias Ekstedt (Stockholm, Sweden)
NAFLD genetics
Quentin Anstee (Newcastle, UK)
Non-invasive assessment of liver fibrosis in NAFLD
Emmanuel Tsochatzis (London, UK)
Novel pharmacotherapy options for NASH
Vlad Ratziu (Paris, France)

Chairpersons: Vlad Ratziu (Paris, France), Emmanuel A. Tsochatzis (London, UK)

The coagulopathy of chronic liver disease
Pier Mannucio Mannucci (Milan, Italy)

Chairperson: Spyridon Dourakis (Athens, Greece)

Diagnostic accuracy of lymphocyte subset profiling in autoimmune diseases
Christoph Jamin (Brest, France)
Lymphocyte subsets as predictors of therapeutic response in autoimmune diseases
TBA
Monocyte populations are altered in autoimmune diseases
Concepción Marañón (Granada, Spain)

Chairperson: Yves Renaudineau (Brest, France)

Diagnostic evaluation of suspected DILI
Ynto de Boer (Amsterdam, The Netherlands)
Management and outcome of DILI in patients with or without chronic liver disease
Alexandra Alexopoulou (Athens, Greece)

Chairperson: Annarosa Floreani (Padova, Italy)

Newsletter signup

Shortest way to explore what will happen at the 9th Athens International Congress of Internal Medicine

Sponsors-Expression of interest

A major exhibition will accompany the Congress, where pharmaceutical and/or equipment/device industries will display relevant products, services and therapeutic developments, reach and interact with the medical community, promote their activities, research and technologies.

For relative information interested Companies may contact the Organizing-Administrative Bureau

Εmail: info@conferre.gr

Tel.: (+30) 26510 68610

Fax: (+30) 26510 68611

Contact person: Mrs Lina Siamopoulou

Register your accomodation now

Beside the main congress hotel, alternative hotels have been reserved for the participants. For further information and terms-conditions please visit registration & accommodation page.

Location